Manorama Industries shareholders approve FY26 results and 40% dividend at AGM

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights
  • Shareholders approved FY26 financial statements and a final dividend of ₹0.80 per share (40%)
  • Revenue grew 76.1% YoY to ₹13,577 million; PAT doubled to ₹2,332 million
  • Net debt-to-equity ratio improved significantly to 0.38 from 0.83
  • All five ordinary resolutions passed with overwhelming majority support
powered bylight_fuzz_icon
51540289

*this image is generated using AI for illustrative purposes only.

Manorama Industries shareholders approved the company’s financial statements for FY26 and declared a final dividend of 40% per equity share during its 21st Annual General Meeting on September 21, 2026. The meeting, conducted via video conference, also saw the reappointment of Whole-Time Director Gautam Kumar Pal.

The Board presented consolidated standalone results showing significant growth in top-line and bottom-line metrics for the fiscal year ended March 31, 2026. Management highlighted robust demand across food and cosmetics sectors as key drivers for the performance. The meeting commenced at 3:00 pm and concluded at 3:48 pm, with 54 members attending virtually.

Financial Performance Highlights

The company reported strong financial outcomes for FY26, reflecting expanded operational leverage and increased contribution from value-added specialty fats. Key standalone metrics disclosed during the proceedings are outlined below.

Metric FY26 FY25 Change
Revenue ₹13,577 million ₹7,708 million +76.1%
EBITDA ₹3,677 million ₹1,911 million +92.4%
PAT ₹2,332 million ₹1,121 million +108.0%
EBITDA Margin 27.1% 24.8% +230 bps

Return on Equity (ROE) improved to 40.3% in FY26 from 28.1% in FY25. Similarly, Return on Capital Employed (ROCE) rose to 33.6% from 19.8%. The net debt-to-equity ratio declined significantly to 0.38 from 0.83, indicating strengthened balance sheet health following a successful Qualified Institutional Placement (QIP).

What the Numbers Show

The divergence between revenue growth (76.1%) and EBITDA growth (92.4%) underscores substantial operating leverage achieved by Manorama Industries in FY26. This expansion in margins coincided with a reduction in working capital days from 151 in FY25 to 125 in FY26, suggesting improved efficiency in cash conversion cycles alongside higher volume throughput.

Governance and Resolutions

Shareholders approved several ordinary resolutions during the AGM. Voting results submitted to exchanges confirm that all resolutions were passed with requisite majority. Key outcomes include:

  • Adoption of audited standalone and consolidated financial statements for FY26 (Passed with 100% votes in favour).
  • Reappointment of Mr. Gautam Kumar Pal as Whole-Time Director upon retirement by rotation (Passed with 99.92% votes in favour).
  • Declaration of final dividend at ₹0.80 per equity share of face value ₹2 each (Passed with 99.99% votes in favour).
  • Ratification of remuneration for Cost Auditors M/s. S N & Co (Passed with 100% votes in favour).
  • Approval of material related-party transactions (Passed with 99.99% votes in favour among non-related parties).

All directors attended the meeting, including Chairman and Managing Director Ashish Ramesh Saraf. Statutory auditors M/s. Singhi & Co., secretarial auditors M/s. B.R. Agarwal & Associates, and internal auditor CLA Indus Value Consulting were present. The voting process was scrutinized by M/s. Mehta & Mehta, Company Secretaries.

Strategic Outlook

Management noted that Q1FY27 revenue grew 39.5% year-on-year, crossing the ₹400 crore quarterly milestone for the first time. Capacity expansions include a 30% increase in Solvent Fractionation Plant-II to 32,500 TPA. The company continues to focus on global expansion with a presence in over 39 countries and strategic investments in Burkina Faso for backward integration.

Historical Stock Returns for Manorama Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-5.99%-12.07%-6.24%+29.25%+16.58%+775.76%

How will the 30% capacity expansion at Solvent Fractionation Plant-II impact Manorama Industries' ability to sustain its recent margin expansion in FY27?

What specific regulatory or geopolitical risks might the strategic backward integration investments in Burkina Faso pose to future supply chain stability?

Given the significant drop in net debt-to-equity ratio post-QIP, how does management plan to allocate the strengthened balance sheet capacity for further global expansion or M&A activities?

Manorama Industries approves ₹30 crore infusion for African subsidiaries

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Approved up to ₹10 crore share capital increase for each of three West African subsidiaries
  • Manorama Africa Benin reported turnover of ₹6.23 crore in FY26
  • Transactions are related party deals conducted on arm's length basis
  • Funds designated for working capital and general corporate purposes
powered bylight_fuzz_icon
51614171

*this image is generated using AI for illustrative purposes only.

Manorama Industries Limited approved an increase in share capital of up to ₹10 crore for each of its three wholly owned subsidiaries in West Africa. The board meeting held on September 22, 2026, authorized these infusions to support working capital requirements and general corporate purposes for entities in Benin, Togo, and Ivory Coast.

The decision aims to strengthen the company's international operations and market presence in the region. The funds will be deployed through cash subscriptions to the increased share capital of the subsidiaries. This move aligns with the company's existing business activities in trading and related sectors.

Subsidiary Details and Capital Allocation

The board approved the capital increase for three specific entities, all incorporated in late 2024 with initial capital of CFA 20 lakh. The allocation is structured as follows:

Subsidiary Name Country Turnover FY26 Proposed Infusion
Manorama Africa Benin Benin ₹6.23 crore Up to ₹10 crore
Manorama Savanna Togo Sarl Togo Nil Up to ₹10 crore
Manorama Africa Savanna Ivory Coast Nil Up to ₹10 crore

Manorama Africa Benin recorded a turnover of approximately ₹6.23 crore during FY26. The other two subsidiaries, Manorama Savanna Togo Sarl and Manorama Africa Savanna, did not record any significant turnover during FY25 or FY26.

Transaction Structure and Compliance

The transactions are classified as related party transactions since the subsidiaries are wholly owned by Manorama Industries. The company stated that the promoter group has no direct interest in these entities beyond their shareholding in the parent company. All transactions are being undertaken on an arm's length basis.

The company intends to complete the transactions in a calibrated and phased manner. This approach ensures efficient capital deployment aligned with business milestones and actual funding needs. The process remains subject to applicable regulatory and statutory approvals in the respective jurisdictions.

What the Numbers Show

The data reveals a strategic divergence in capital deployment across the African footprint. While all three subsidiaries receive identical maximum authorizations of ₹10 crore, only Manorama Africa Benin demonstrates immediate revenue traction with a turnover of ₹6.23 crore. The other two entities, incorporated in September and October 2024 respectively, remain pre-revenue. This suggests that while the parent company is standardizing its financial backing across the region, operational maturity varies significantly, with Benin serving as the current primary revenue generator among the new ventures.

Historical Stock Returns for Manorama Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-5.99%-12.07%-6.24%+29.25%+16.58%+775.76%

How will the phased capital deployment strategy impact Manorama Industries' short-term liquidity and cash flow management?

What specific regulatory or political risks in Benin, Togo, and Ivory Coast could delay the finalization of these cross-border capital infusions?

Given the pre-revenue status of the Togo and Ivory Coast subsidiaries, what are the projected timelines for them to achieve operational break-even?

More News on Manorama Industries

1 Year Returns:+16.58%